NeoGenomics specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. The Company also serves pharmaceutical clients in clinical trials and drug development. As the leader in hematologic oncology testing, Neo offers a 500+ test menu, including comprehensive genomic profiling in hematologic cancers, broad portfolio of HemeFISH™ and Flow panels and cytogenetics.